BAYN48.41+5.17%
BAYN · DAX
1y range: 34.10 → 48.41 · as of 2026-06-30
Next earnings
2026-08-04
in 32d
Recent material news
- BAYER AG : JP Morgan bevestigt koopadvies - MarketScreener Nederland — MarketScreener Nederland2026-06-25T17:01
- Aandelen Bayer schieten omhoog na gunstige uitspraak Amerikaans Hooggerechtshof - MarketScreener Nederland — MarketScreener Nederland2026-06-25T14:23
- Bayer AG : Sadif Investment Analytics verlaagt advies van Neutraal naar Verkopen - MarketScreener Nederland — MarketScreener Nederland2026-06-19T13:04
- Bayer neemt hindernis voor schikking glyfosaat: aandeel stijgt - MarketScreener Nederland — MarketScreener Nederland2026-06-18T06:22
- BAYER AG : Jefferies is Neutraal over het aandeel - MarketScreener Nederland — MarketScreener Nederland2026-06-17T20:01
- Bayer Aktiengesellschaft (XTRA: BAYN) voltooit overname van Perfuse Therapeutics, Inc. - MarketScreener Nederland — MarketScreener Nederland2026-06-17T12:36
- Bayer Completes Acquisition of Perfuse Therapeutics2026-06-17T06:30
- Bayer’s AMBELVIST® (gadoquatrane) Receives FDA Approval for Contrast-Enhanced MRI to Detect and Visualize Lesions with Abnormal Vascularity in the Central Nervous System and Non-CNS Body Regions2026-06-15T06:30
Want this depth on every stock you watch?
ThickerPeek writes a daily AI digest on 165+ stocks, weekly theses, earnings briefings, and alerts — for €19/mo. Free tier available.
Not investment advice. ThickerPeek is a research tool. AI-written content is informational, not a buy/sell recommendation. Investment decisions are your own responsibility.